Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
CNSP

CNS Pharmaceuticals (CNSP) stock: insider trades, news & valuation

Health Care · Net buying
Close · Oct 9, 2026 $5.35 +0.0% on the day -46.8% over 12 months 52-week range $2.13 – $10.05

Share price and insider trades

CNSP closeInsider buyInsider sale
02581012NovDecJan 2026FebMarAprMayJunJulAugSepOctBought $44,009 on 2026-05-18 · Faith L. Charles, Michal Fisher
Bought, 12 months$44K
Sold, 12 months$0
Insiders buying2
Insiders selling0

CNS Pharmaceuticals insider trading at a glance (Oct 9, 2026): in the past 12 months, 2 insiders bought $44K and 0 sold $0 of CNSP stock on the open market.

CNSP insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q2 2026: $44K bought (2 trades)$44KQ2 2026Q3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026—0—0
Q2 2026$44K2—0

Valuation, profit and volume

P/E (trailing)n/aSector median 24.7
Market value$7.8MBiotechnology
Profit margin0.0%Revenue growth —
Volume vs. 50-day0.5×Last 5 sessions
Insiders' paper profit+$5KOn all tracked purchases +10.6%

Summary

Over the past 12 months, 2 CNS Pharmaceuticals, Inc. insiders reported open-market purchases totaling $44K, while 0 insiders reported sales totaling $0.

CNSP stock news and SEC filings

Recent 8-K filings and headlines. Tone is scored from the headline wording; “Policy” marks regulatory, trade or government topics.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Aug 18SEC Michal FisherDirector Buy 2,000new position $5.00 $10K +7.0% —
May 20SEC Faith L. CharlesDirector Buy 7,100new position $4.79 $34K +11.7% —

Insiders at CNS Pharmaceuticals, Inc.

InsiderBoughtSoldLast filingScore
Faith L. CharlesDirector $34K — May 20, 2026 —
Michal FisherDirector $10K — Aug 18, 2026 —

Insider activity at other Health Care companies

Same sector, ranked by insider buying in the last 90 days.

  • SLBTSL Science Holding Ltd$10329.90B bought
  • KODKodiak Sciences Inc.$157M bought
  • ADRXADARx Pharmaceuticals, Inc.$87.7M bought
  • ATTOAttovia Therapeutics, Inc.$72.9M bought
  • MPLTMapLight Therapeutics, Inc.$65.5M bought
  • AVRAnteris Technologies Global Corp.$40.4M bought

CNSP stock: common questions

Are CNS Pharmaceuticals, Inc. insiders buying CNSP stock?

In the past 12 months, 2 insiders reported open-market purchases of CNSP worth $44K. The latest was Director Michal Fisher bought $10K of CNSP at $5.00 — first open-market purchase in our records; opens a new position.

Are CNS Pharmaceuticals, Inc. insiders selling CNSP stock?

0 insiders reported sales worth $0 over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is CNSP's 52-week range?

Over the past year CNSP has traded between $2.13 and $10.05. It last closed at $5.35 on Oct 9, 2026.